U.S. Markets closed

Horizon Pharma Public Limited Company (HZNP)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
13.16+0.29 (+2.25%)
At close: 4:00PM EDT

13.16 0.00 (0.00%)
After hours: 5:20PM EDT

People also watch
DEPOSRPTFOLDJUNORDUS
  • KTOV = Mcap $16 Mil /Cash $17 Mil / ULTRA Low float O/S 10.6 M / NDA submission for potential Blockbuster this Quarter = 20 BAGGER ..ONE OF THE BIGGEST BIOTECH OPPORTUNITY EVER ! Thank me later guys

    Kitov Pharma (KTOV)

    Market Cap: $17 M
    Cash $17 M
    Price: $1.50

    Shares Out: 10.6 Million

    Kitov Pharmaceuticals Initiates NDA Filing for KIT-302 as a Treatment for Osteoarthritis and Hypertension
    https://baystreet.ca/articles/research_reports/lifesci/Kitov062717.pdf

    Kitov Expects to Submit an NDA for KIT-302 in the Third Quarter 2017.Kitov announced that it began the process of compiling the documents necessary to file an NDA for its lead asset KIT-302 as a treatment for patients who experience both osteoarthritis and hypertension. The Company hired Parexel International Corporation, a clinical research organization, to digitalize and formally submit its NDA application. Kitov expects the filing to occur during the third quarter of 2017, with a potential FDA approval during the second quarter of 2018.

    KIT-302 is a combination drug that treats osteoarthritis pain and hypertension simultaneously

    Primary efficacy endpoint achieved Lead drug candidate KIT-302 achieved its primary efficacy endpoint in a pivotal Phase III trial

    Marketing potential Pipeline candidates address large, multi-billion dollar markets

    “KIT-302 has the potential to address the multi-billion dollar market for the treatment of osteoarthritis pain and hypertension with one drug that reduces patients’ risk of suffering a heart attack or stroke, while also reducing cost for payers. There is currently no single medication on the market that treats both osteoarthritis pain and hypertension and thus, KIT-302 will be the only NSAID indicated both to treat pain and to reduce the risk of heart attack, stroke and death.”

    Pain medications for osteoarthritis account for billions of dollars in annual sales globally. Most pain medications for osteoarthritis, including celecoxib which had global sales of $2.7 billion in 2014, are non-steroidal anti-inflammatory drugs (NSAIDs) which have the side effect of elevating blood pressure, and increasing the risk of heart attacks, strokes and death. Of the 27 million Americans who live with osteoarthritis, 13.5 million also suffer from hypertension, which also increases the risk of heart attack, stroke, and death.

  • Here we go again with Democrats trying to "Get A Better Deal" and trying to go after drug companies again to lower prices.
    We'll see what this announcement has on the IBB and Horizon in the coming days.
    The republicans didn't get anything accomplished, so I don't see this getting traction from the Dems.
    Thoughts from anyone?
  • #$%$, Schumer was on the ABC political show today, saying the democrats are going to launch a new attack against high drug prices starting tomorrow. That's not good for drug stocks.
  • The Creepy Lying Schumer-Pelosi Warmed-Over Marxism the Dems came up with today in part threatening drug companies had
    little or no effect on the markets, as far as I know. Healthcare down just a touch but Nasdaq up okay and of course our shares did well. I say we all march on Washington, find Schumer and put rabid schmeckel-biting squirrels down his pants and throw that old crone Pelosi into the Reflecting Pool, where she can swim with her sister barracuda! Yeah, I said it, and I'm glad I did. It had to be said, and now it can be done.
  • HZNP, looks to be overvalued at this price check out awe.SOME-Stock-S, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • Comon Horizon, give us a surge!
  • Both IBB and BIB jumped a lot after hours. What happed in bio sector?
  • I see HZNP has an estimate of .12 cents which is a recent low. Any one have any educated guesses on whether they will beat it or not?
  • This bastid gave us all some pretty good headaches last year: https://finance.yahoo.com/news/letter-martin-shkreli-hope-see-134740449.html

    Letter from Martin Shkreli: "I Hope To See You and Your Four Children Homeless"
    Letter from Martin Shkreli: "I Hope To See You and Your Four Children Homeless"
    finance.yahoo.com
  • Guess $13.00 is the target for option expiration this Friday.
    GLTA
  • Thanks for the tip, I did some research and found more information about $HZNP on http://jcharlesassets.com/opiant-pharmaceuticals/?s=HZNP "hhse" Trading stocks day trading.

    Best MicroCap, Small Cap and Emerging Stocks to Buy - J Charles Assets
    We search for the smart new growing companies to invest in with stock deals to watch in pharmacuetical and digital verticals.
    jcharlesassets.com
  • It is extremely likely this stock will be north of $20 within 12 months.
  • Anyone see any news after hours? Why a $0.38 jump?
  • glad I took a little off the table at 13.16.
  • [!] Newly updated to now include all possible spread combinations - Option spread traders have a look at CreditSpreads.io, cost free live table of mathematically profitable option credit spreads for the following 4 weeks, sometimes including spreads for HZNP! High probability option credit spreads provide you with a means to invest with determined risk and the max profit received right away. CreditSpreads.io targets solely the credit spreads which meet its rigid standards for risk and profit, and ensures sustained profitability by telling you of any impending events which can affect the trade. http://www.creditspreads.io

    CreditSpreads.io
    Sustainable, high probability, defined risk stock option trading opportunities.
    www.creditspreads.io
  • [!] Recently updated to now display all available spreads - Option spread traders check out CreditSpreads.io, free live list of statistically profitable option credit spreads for the next month, sometimes including spreads for HZNP! High probability option credit spreads present a technique to trade with specified risk and the max profit received right away. CreditSpreads.io targets solely the option spreads which fulfill its strict standards for risk and profit, and ensures continued profitability by warning you of any upcoming situations that could affect the trade. http://www.creditspreads.io

    CreditSpreads.io
    Sustainable, high probability, defined risk stock option trading opportunities.
    www.creditspreads.io
  • AFTER HOURS VOLUME UP .02 cents
    547,859
    GLTA
  • I expect 16 to 18 by year end. 22 to 25 by end of 2018.
  • took a little off the table at 13.16. still have plenty of shares. if for some reason there is a big correction I will re buy. if it keeps going up I make money. can't lose .
  • On June 19,2017 HZNP announced the following
    "Horizon Therapeutics Canada, today announced that Health Canada has issued a Notice of Compliance (NOC) for PROCYSBI™ (cysteamine delayed-release capsules) for the treatment of nephropathic cystinosis in adults and children 2 years of age and older."
    How soon could we see a bump in sales from this news and what kind of $$$$ are we talking?
    GLTA